Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
2.09 EUR
−23.00 M EUR
2.23 M EUR
16.35 M
About OSE IMMUNOTHERAPEUTICS
Sector
CEO
Nicolas Poirier
Headquarters
Nantes
Website
Founded
2004
ISIN
FR0012127173
FIGI
BBG00JHW6XN5
OSE Immunotherapeutics SA s is a biotechnology company, which engages in the research and development of pharmaceutical products. It focuses on developing and partnering therapies to control the immune system for immuno-oncology and immuno-inflammation. The company was founded by Dominique Constantini on November 17, 2004 and is headquartered in Nantes, France.
An aggregate view of professional's ratings.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of 0RAD is 8.84 EUR — it has increased by 1.14% in the past 24 hours. Watch OSE IMMUNOTHERAPEUTICS EUR0.20 stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on LSE exchange OSE IMMUNOTHERAPEUTICS EUR0.20 stocks are traded under the ticker 0RAD.
0RAD stock has fallen by −4.95% compared to the previous week, the month change is a −9.24% fall, over the last year OSE IMMUNOTHERAPEUTICS EUR0.20 has showed a 91.55% increase.
We've gathered analysts' opinions on OSE IMMUNOTHERAPEUTICS EUR0.20 future price: according to them, 0RAD price has a max estimate of 14.00 EUR and a min estimate of 10.80 EUR. Watch 0RAD chart and read a more detailed OSE IMMUNOTHERAPEUTICS EUR0.20 stock forecast: see what analysts think of OSE IMMUNOTHERAPEUTICS EUR0.20 and suggest that you do with its stocks.
0RAD reached its all-time high on Mar 3, 2021 with the price of 13.65 EUR, and its all-time low was 2.73 EUR and was reached on Aug 29, 2023. View more price dynamics on 0RAD chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
0RAD stock is 1.13% volatile and has beta coefficient of 0.95. Track OSE IMMUNOTHERAPEUTICS EUR0.20 stock price on the chart and check out the list of the most volatile stocks — is OSE IMMUNOTHERAPEUTICS EUR0.20 there?
Today OSE IMMUNOTHERAPEUTICS EUR0.20 has the market capitalization of 188.17 M, it has decreased by −2.05% over the last week.
Yes, you can track OSE IMMUNOTHERAPEUTICS EUR0.20 financials in yearly and quarterly reports right on TradingView.
OSE IMMUNOTHERAPEUTICS EUR0.20 is going to release the next earnings report on Mar 27, 2025. Keep track of upcoming events with our Earnings Calendar.
0RAD net income for the last half-year is 57.17 M EUR, while the previous report showed −11.14 M EUR of net income which accounts for 613.10% change. Track more OSE IMMUNOTHERAPEUTICS EUR0.20 financial stats to get the full picture.
No, 0RAD doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Nov 21, 2024, the company has 55.00 employees. See our rating of the largest employees — is OSE IMMUNOTHERAPEUTICS EUR0.20 on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. OSE IMMUNOTHERAPEUTICS EUR0.20 EBITDA is 36.34 M EUR, and current EBITDA margin is −1.30 K%. See more stats in OSE IMMUNOTHERAPEUTICS EUR0.20 financial statements.
Like other stocks, 0RAD shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade OSE IMMUNOTHERAPEUTICS EUR0.20 stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So OSE IMMUNOTHERAPEUTICS EUR0.20 technincal analysis shows the neutral today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating OSE IMMUNOTHERAPEUTICS EUR0.20 stock shows the buy signal. See more of OSE IMMUNOTHERAPEUTICS EUR0.20 technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.